A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials

The recent prospect of pharmaceutical interventions for cognitive impairment of Down syndrome (DS) has boosted a number of clinical trials in this population. However, running the trials has raised some methodological challenges and questioned the prevailing methodology used to evaluate cognitive fu...

Descripción completa

Detalles Bibliográficos
Autores principales: de Sola, Susana, de la Torre, Rafael, Sánchez-Benavides, Gonzalo, Benejam, Bessy, Cuenca-Royo, Aida, del Hoyo, Laura, Rodríguez, Joan, Catuara-Solarz, Silvina, Sanchez-Gutierrez, Judit, Dueñas-Espin, Ivan, Hernandez, Gimena, Peña-Casanova, Jordi, Langohr, Klaus, Videla, Sebastia, Blehaut, Henry, Farre, Magi, Dierssen, Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Psychology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455308/
https://www.ncbi.nlm.nih.gov/pubmed/26089807
http://dx.doi.org/10.3389/fpsyg.2015.00708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455308/
https://www.ncbi.nlm.nih.gov/pubmed/26089807
http://dx.doi.org/10.3389/fpsyg.2015.00708

Ejemplares similares